Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome

NCT01818505 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01818505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01818505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
Not reported
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, endothelial dysfunction, gout, hyperuricemia, metabolic syndrome